Accelerate Protein Screening by Sequencing Protein Barcodes on Platinum®
On-demand webinar presented by Joel McDade, PhD, Sr. Commercial Business Development Manager, Quantum-Si and Bonnie Lun, PhD, Field Application Scientist
Challenges and Strategies for the Application of Omics and Spatial Technologies
A concise report featuring insights from the prominent thought leaders of Omics 2023 and Spatial 2024
A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics
On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Biomarker Discovery & Development
Spatial Biomarkers & Multiplexed Immunofluorescence in Immuno-Oncology
Yu Liang, Director of Clinical Biomarkers at Compugen, leads a discussion on ‘Spatial Biomarkers & Multiplexed Immunofluorescence in Immuno-Oncology.’
Spatial Analysis
Omics US 2022: The Epicentre of the Spatial Omic Conversation
Showcasing the highlights from NextGen Omics: In-Person 2022. We asked Alex Tamburino, Associate Principal Scientist at Merck about his experience at the event.
Spatial Analysis
Spatial Single Cell Metabolomics | Mass Spectrometry & Microscopy Integration
In Conversation With Theodore Alexandrov, Team Leader, European Molecular Biology Laboratory
Genome Editing
Showcasing Bleeding-Edge Genome Editing Companies: NextGen Omics US
Gábor Balázsi, Henry Laufer Professor of Physical and Quantitative Biology at Stony Brook University, takes us through the most valuable features that NextGen Omics US brought us in 2022.
Clinical Diagnostics
De Novo Variants: Genomic Sequencing and Problem Solving for Future Treatments
In this Commentary article, we investigate the application of new research techniques to inspecting genomic data for the presence of de novo variants - genetic alterations present for the first time in one individual as a result of a variant inherited from a parent. Used in combination with data from the 100,000 Genome Project, these techniques could reduce the time taken for patients to receive a diagnosis for rare genetic diseases.
Biomarker Discovery & Development
What’s Next for Predictive Biomarkers in Immunotherapy?
From maximising immune response with combination biomarkers to conducting diagnostic innovation in immunotherapy prognosis, the future of predictive biomarkers is fast approaching. We speak to senior representatives from industry and academia to find out more.
Biomarker Discovery & Development
Developing a biomarker? Keep these 3 takeaways in mind
Three key take aways when you develop biomarkers: one during biomarker discovery, one during biomarker development and one during biomarker validation.
Biomarker Discovery & Development
The 5 most common pitfalls when developing biomarkers
Discovering a strong biomarker is an expensive and time-consuming process. One of the key takeaways is to take your time and look at the data before you start testing for biomarkers.
Biomarker Discovery & Development
The future of biomarkers: where are they heading?
Biomarkers come in many shapes and sizes. It’s an ever-evolving subject with many under-discovered possibilities. Let’s look at some ways biomarkers are looking to evolve.
Spatial Analysis
A Spatial Examination of The Brain - From Development To Disease At The Subcellular Level
Rebus Biosystems has assembled five collaborators to share aspects of their cellular examinations of the human brain. From new strides in understanding brain development to exploring the sub cellular details of disease, these presentations illustrate the array of knowledge gained through cellular spatial exploration.
DPCR
Exploring Advanced Multiplex Assays
This month’s discussion was led by Pieter van der Velden. Topics included improving multiplex assays, T-Cell quantification and DNA methylation.
Single Cell Analysis
Single Cell Proteomics: Sample Preparation and Tissue Selection
Single-cell proteomics has developed quickly, despite being a relatively new field. NanoPOTS and FACS are being used to improve proteome coverage and minimise sample size.